Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile. 2015

Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
Département de Biologie, Faculté des Sciences, Université de Sherbrooke, QC, Canada.

Clostridium difficile is an anaerobic Gram-positive bacterium that causes intestinal infections with symptoms ranging from mild diarrhea to fulminant colitis. Cyclic diguanosine monophosphate (c-di-GMP) is a bacterial second messenger that typically regulates the switch from motile, free-living to sessile and multicellular behaviors in Gram-negative bacteria. Increased intracellular c-di-GMP concentration in C. difficile was recently shown to reduce flagellar motility and to increase cell aggregation. In this work, we investigated the role of the primary type IV pilus (T4P) locus in c-di-GMP-dependent cell aggregation. Inactivation of two T4P genes, pilA1 (CD3513) and pilB1 (CD3512), abolished pilus formation and significantly reduced cell aggregation under high c-di-GMP conditions. pilA1 is preceded by a putative c-di-GMP riboswitch, predicted to be transcriptionally active upon c-di-GMP binding. Consistent with our prediction, high intracellular c-di-GMP concentration increased transcript levels of T4P genes. In addition, single-round in vitro transcription assays confirmed that transcription downstream of the predicted transcription terminator was dose dependent and specific to c-di-GMP binding to the riboswitch aptamer. These results support a model in which T4P gene transcription is upregulated by c-di-GMP as a result of its binding to an upstream transcriptionally activating riboswitch, promoting cell aggregation in C. difficile.

UI MeSH Term Description Entries
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D010861 Fimbriae, Bacterial Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX). Bacterial Fimbriae,Bacterial Pili,Common Fimbriae,Common Pili,Pili, Bacterial,Pili, Common,Bacterial Fimbria,Bacterial Pilus,Common Fimbria,Common Pilus,Fimbria, Bacterial,Pilus, Bacterial,Fimbria, Common,Fimbriae, Common,Pilus, Common
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D012329 RNA, Bacterial Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis. Bacterial RNA
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial
D016360 Clostridioides difficile A common inhabitant of the colon flora in human infants and sometimes in adults. The type species Clostridioides difficile is formerly known as Clostridium difficile. It is a causative agent for CLOSTRIDIOIDES INFECTIONS and is associated with PSEUDOMEMBRANOUS ENTEROCOLITIS in patients receiving antibiotic therapy. Clostridium difficile
D058928 Riboswitch Part of a MESSENGER RNA molecule that undergoes a conformation change upon binding a specific metabolite or other small molecule thereby regulating the messenger RNA's transcription, post-transcriptional processing, transport, translation, or stability in response to varying levels of the metabolite or other small molecule. Riboswitches,Ribosensor,Ribosensors

Related Publications

Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
November 2015, Current genetics,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
August 2016, Pathogens and disease,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
March 2014, Molecular bioSystems,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
July 2016, Scientific reports,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
April 2017, Journal of bacteriology,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
November 2013, Journal of bacteriology,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
January 2016, Journal of bacteriology,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
May 2018, Infection and immunity,
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
February 2015, Structure (London, England : 1993),
Eric Bordeleau, and Erin B Purcell, and Daniel A Lafontaine, and Louis-Charles Fortier, and Rita Tamayo, and Vincent Burrus
February 2012, Journal of bioscience and bioengineering,
Copied contents to your clipboard!